# Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms

> **NCT00343174** · PHASE3 · COMPLETED · sponsor: **Heidelberg University**

## Conditions studied

- Brain Infarction
- Cerebral Ischemia
- Acute Stroke

## Interventions

- **DRUG:** Ancrod

## Key facts

- **NCT ID:** NCT00343174
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343174, "Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00343174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*